NeoSome Life Sciences
NeoSome Life Sciences is an innovative contract research organization dedicated to providing the latest therapeutic research and supporting drug discovery through various in vitro and in vivo models, assays, and animal studies. Located in Billerica, Massachusetts, the company emphasizes high-quality animal care, advanced facilities, and a broad range of research services to support biotech, pharmaceutical, academic, and government clients.
Industries
Nr. of Employees
small (1-50)
NeoSome Life Sciences
Products
Flow Cytometry Services
Flow cytometry services (up to 14 colors) with applications in immunotherapy including cellular therapies, bi-specific T Cell engagers, checkpoint inhibitors, vaccines, and various immune modulators.
MSD
High sensitivity and specificity MSD assay services using standard and custom panels with low sample volumes.
ELISA
Preclinical ELISA testing services utilizing standard and custom panels.
Neutropenic models
Thigh and lung infection models utilizing neutropenic animals.
Subcutaneous Pouch Models
Subcutaneous pouch model services for specialized anti-infective agent evaluations.
Mouse subcutaneous abscess model
In vivo rodent model for evaluating test agents in subcutaneous abscess conditions.
Flow Cytometry Services
Flow cytometry services (up to 14 colors) with applications in immunotherapy including cellular therapies, bi-specific T Cell engagers, checkpoint inhibitors, vaccines, and various immune modulators.
MSD
High sensitivity and specificity MSD assay services using standard and custom panels with low sample volumes.
ELISA
Preclinical ELISA testing services utilizing standard and custom panels.
Neutropenic models
Thigh and lung infection models utilizing neutropenic animals.
Subcutaneous Pouch Models
Subcutaneous pouch model services for specialized anti-infective agent evaluations.
Mouse subcutaneous abscess model
In vivo rodent model for evaluating test agents in subcutaneous abscess conditions.
Services
Turn-key or customized rodent disease model studies across infectious disease, oncology, metabolic, inflammation and behavioral endpoints.
Tolerability testing, single and multiple dose PK studies, infusion and cassette dosing, exposure modeling, and formulation evaluations to support dosing strategies.
Custom and kit-based immunoassays, multiplex electrochemiluminescence assays, ELISA, cell-based assays, qPCR and western blot for biomarker and target analysis.
Multicolor immunophenotyping and functional cell assays for immune monitoring, biomarker identification and cell therapy-related testing.
In-house automated hematology and clinical chemistry panels optimized for small-volume samples from multiple species, with fresh-sample workflows.
Longitudinal in vivo optical imaging for oncology studies and histology/pathology support for tissue-based endpoints.
Turn-key or customized rodent disease model studies across infectious disease, oncology, metabolic, inflammation and behavioral endpoints.
Tolerability testing, single and multiple dose PK studies, infusion and cassette dosing, exposure modeling, and formulation evaluations to support dosing strategies.
Custom and kit-based immunoassays, multiplex electrochemiluminescence assays, ELISA, cell-based assays, qPCR and western blot for biomarker and target analysis.
Multicolor immunophenotyping and functional cell assays for immune monitoring, biomarker identification and cell therapy-related testing.
In-house automated hematology and clinical chemistry panels optimized for small-volume samples from multiple species, with fresh-sample workflows.
Longitudinal in vivo optical imaging for oncology studies and histology/pathology support for tissue-based endpoints.
Expertise Areas
- Preclinical in vivo model development
- In vitro assay development and execution
- Pharmacokinetics and pharmacodynamics (PK/PD)
- Infectious disease models and antimicrobial testing
Key Technologies
- Electrochemiluminescence multiplex immunoassays
- Multicolor flow cytometry (up to 14-color)
- Enzyme-linked immunosorbent assays (ELISA)
- Cell-based cytotoxicity and viability assays (MTT, clonogenic)
News & Updates
NeoSome has received accreditation from the AAALAC International, demonstrating high standards of animal care and welfare.
NeoSome has expanded to a new state-of-the-art facility in Billerica, MA, with increased capacity and support for research programs.
NeoSome has expanded its services and models, including in vitro assays and in vivo models, to support early drug discovery.
NeoSome will participate in the RESI Conference in Boston, MA, to discuss early-stage research collaborations.
NeoSome has achieved accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International, ensuring high standards of animal welfare.
NeoSome has received accreditation from the AAALAC International, demonstrating high standards of animal care and welfare.
NeoSome has expanded to a new state-of-the-art facility in Billerica, MA, with increased capacity and support for research programs.
NeoSome has expanded its services and models, including in vitro assays and in vivo models, to support early drug discovery.
NeoSome will participate in the RESI Conference in Boston, MA, to discuss early-stage research collaborations.
NeoSome has achieved accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International, ensuring high standards of animal welfare.